Skip to main content
FinSpry Logo
FinSpry
FHTX logo
FHTX
(NASDAQ)
Foghorn Therapeutics Inc.
$4.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Foghorn Therapeutics (FHTX) Stock Price & Financial Analysis

Foghorn Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.61 - $4.02
52-Week High$6.95
52-Week Low$3.27
Open$3.61
Volume245.94K
Average Volume (3M)137.36K
Market Cap240.59M
Shares Outstanding62.98M
Price to Sales (P/S)7.72
Price to Book (P/B)-2.20
EV/EBITDA-2.53
Revenue (TTM)30.91M
Net Income (TTM)-74.28M
Free Cash Flow (TTM)-86.15M
EPS (TTM)$-1.18
Profit Margin-240.33%
Operating Margin-265.64%
50-Day MA$4.97
200-Day MA$5.02
52-Week Change-2.26%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Foghorn Therapeutics

What is the current stock price for FHTX?

As of the latest trading session, FHTX stock trades at $4.00. The 52-week range is $3.27–$6.95, with a day range of $3.61–$4.02.

What is the P/E ratio for FHTX?

The P/E ratio (Price-to-Earnings) for FHTX is shown in the Key Statistics section. This valuation metric helps compare Foghorn Therapeutics Inc. to industry peers.

Does FHTX pay dividends?

Foghorn Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for FHTX?

Based on 2 analysts, the consensus for FHTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of FHTX?

Foghorn Therapeutics's market capitalization is $251.9M, classifying it as a micro-cap company. Foghorn Therapeutics operates in the Healthcare sector within the Biotechnology industry.